CVCapsoVision, Inc.
$6.98+41% 1Y
$6.98
$4.5952 weeks$14.42
Is the price fair?
What CV's price assumes
CapsoVision, Inc. did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 27.3× revenue.
27.3
Price / sales · no P/E: the last twelve months did not end in a profit
- Price / book
- 28.8
Price / book · as of 2026-Q2
Details›
- Price / bookas of 2026-Q2
- 28.8
- EV / EBIToperating margin −217%: the multiple describes the denominator
- not meaningful
- Market capitalisation50.0 million shares, counted Aug 12, 2026
- $349M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Medical Devices
The closest names by size in the same industry